Sandoz Canada Inc.
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Discuss matters related to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|
|
Improve regulatory environment and utilization rates for generics and biosimilars.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|
|
Raising awareness to government officials about the challenge of drug supply in the context of Covid-19 and post-Covid-19.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
Health
|
|
Raising awareness to government officials for generic and biosimilar products development by Sandoz Canada Inc. and the potential savings realized by the healthcare system.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|